Omicron Subvariant BA.2 now accounts for nearly 25% of new US COVID cases being sequenced

By Deadline
| March 16, 2022

In the second and third weeks of March, the percentage of new U.S. cases sequenced that were attributed to BA.2 was nearly 1 in 4, or 23%.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...